A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patients
Published inAntiviral therapy, vol. 10, no. 6, p. 761-767
Publication date2005
Abstract
Keywords
- Adult
- Anti-HIV Agents/administration & dosage/adverse effects/therapeutic use
- Antiretroviral Therapy, Highly Active/ adverse effects
- CD4 Lymphocyte Count
- Drug Therapy, Combination
- Female
- HIV Infections/ drug therapy/virology
- HIV-1/drug effects
- Humans
- Male
- Prospective Studies
- RNA, Viral/blood
- Reverse Transcriptase Inhibitors/administration & dosage/adverse
- Effects/ therapeutic use
- Ritonavir/administration & dosage/adverse effects/therapeutic use
- Saquinavir/administration & dosage/adverse effects/therapeutic use
- Thailand
- Treatment Outcome
Affiliation
Citation (ISO format)
ANANWORANICH, Jintanat et al. A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patients. In: Antiviral therapy, 2005, vol. 10, n° 6, p. 761–767.
Updates (1)
Article

Identifiers
- PID : unige:7079
- PMID : 16218176
ISSN of the journal1359-6535